FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899765159> ?p ?o ?g. }

• W2899765159 endingPage "e11441" @default.
• W2899765159 startingPage "e11441" @default.
• W2899765159 abstract "The cardiac surgery-induced systemic inflammatory response may induce postoperative hemodynamic instability and impairment of renal function. EA-230, a linear tetrapeptide (A-Q-G-V), is derived from the beta chain of the human chorionic gonadotropin pregnancy hormone. It has shown immunomodulatory and renoprotective effects in several animal models of systemic inflammation. In phase 1 and phase 2a studies, these immunomodulatory effects were confirmed during human experimental endotoxemia, and EA-230 was found to have an excellent safety profile.The objective of this first in-patient study is to test the safety and tolerability as well as the immunomodulatory and renoprotective effects of EA-230 in a proof-of-principle design in patients with systemic inflammation following on-pump cardiac surgery.We describe a prospective, randomized, double-blind, placebo-controlled study in which 180 elective patients undergoing on-pump coronary artery bypass grafting, with or without concomitant valve surgery, are enrolled. Patients will be randomized in a 1:1 ratio and will receive either EA-230 (90 mg/kg/hour) or a placebo. These will be infused at the start of the surgical procedure until the end of the use of the cardiopulmonary bypass. The primary focus of this first-in-patient study will be on safety and tolerability of EA-230. The primary efficacy end point is the modulation of the inflammatory response by EA-230 quantified as the change in interleukin-6 plasma concentrations after surgery. The key secondary end point is the effect of EA-230 on renal function. The study will be conducted in 2 parts to enable an interim safety analysis by an independent data monitoring committee at a sample size of 60. An adaptive design is used to reassess statistical power halfway through the study.This study has been approved by the independent competent authority and ethics committee and will be conducted in accordance with the ethical principles of the Declaration of Helsinki, guidelines of Good Clinical Practice, and European Directive 2001/20/CE regarding the conduct of clinical trials. Results of this study will be submitted for publication in a peer-reviewed scientific journal. Enrollment of this study commenced in July 2016, and results are expected at the end of 2018.This adaptive phase 2 clinical study is designed to test the safety and tolerability of EA-230 in patients undergoing cardiac surgery. In addition, efficacy end points focused on the effect of the systemic inflammatory response and renal function are investigated.ClinicalTrials.gov NCT03145220; https://clinicaltrials.gov/ct2/show/NCT03145220 (Archived by WebCite at http://www.webcitation.org/74JPh8GNN).DERR1-10.2196/11441." @default.
• W2899765159 created "2018-11-16" @default.
• W2899765159 creator A5022233224 @default.
• W2899765159 creator A5025445136 @default.
• W2899765159 creator A5027651871 @default.
• W2899765159 creator A5028600581 @default.
• W2899765159 creator A5039420443 @default.
• W2899765159 creator A5064342139 @default.
• W2899765159 creator A5065320081 @default.
• W2899765159 date "2019-02-06" @default.
• W2899765159 modified "2023-10-08" @default.
• W2899765159 title "The Safety, Tolerability, and Effects on the Systemic Inflammatory Response and Renal Function of the Human Chorionic Gonadotropin Hormone-Derivative EA-230 Following On-Pump Cardiac Surgery (The EASI Study): Protocol for a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study" @default.
• W2899765159 cites W1511621323 @default.
• W2899765159 cites W1525619222 @default.
• W2899765159 cites W1702536112 @default.
• W2899765159 cites W1984213393 @default.
• W2899765159 cites W2002926363 @default.
• W2899765159 cites W2008307832 @default.
• W2899765159 cites W2008519253 @default.
• W2899765159 cites W2014784085 @default.
• W2899765159 cites W2030190637 @default.
• W2899765159 cites W2051719200 @default.
• W2899765159 cites W2054173730 @default.
• W2899765159 cites W2054193305 @default.
• W2899765159 cites W2054938569 @default.
• W2899765159 cites W2056180828 @default.
• W2899765159 cites W2059707463 @default.
• W2899765159 cites W2063377993 @default.
• W2899765159 cites W2070755681 @default.
• W2899765159 cites W2077424606 @default.
• W2899765159 cites W2078021680 @default.
• W2899765159 cites W2089226005 @default.
• W2899765159 cites W2092599472 @default.
• W2899765159 cites W2094581349 @default.
• W2899765159 cites W2099773735 @default.
• W2899765159 cites W2115157570 @default.
• W2899765159 cites W2133772134 @default.
• W2899765159 cites W2134544157 @default.
• W2899765159 cites W2136871445 @default.
• W2899765159 cites W2138483553 @default.
• W2899765159 cites W2139937737 @default.
• W2899765159 cites W2141559993 @default.
• W2899765159 cites W2142155616 @default.
• W2899765159 cites W2151351508 @default.
• W2899765159 cites W2155490586 @default.
• W2899765159 cites W2161099242 @default.
• W2899765159 cites W2166169466 @default.
• W2899765159 cites W2167138255 @default.
• W2899765159 cites W2171130674 @default.
• W2899765159 cites W2171811563 @default.
• W2899765159 cites W2220742453 @default.
• W2899765159 cites W2321907341 @default.
• W2899765159 cites W2430394288 @default.
• W2899765159 cites W2468673334 @default.
• W2899765159 cites W2517255048 @default.
• W2899765159 cites W2749921476 @default.
• W2899765159 cites W2768146862 @default.
• W2899765159 cites W2926501765 @default.
• W2899765159 cites W2929646395 @default.
• W2899765159 cites W4244461007 @default.
• W2899765159 cites W4245937032 @default.
• W2899765159 cites W4252306088 @default.
• W2899765159 doi "https://doi.org/10.2196/11441" @default.
• W2899765159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6381408" @default.
• W2899765159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30724734" @default.
• W2899765159 hasPublicationYear "2019" @default.
• W2899765159 type Work @default.
• W2899765159 sameAs 2899765159 @default.
• W2899765159 citedByCount "9" @default.
• W2899765159 countsByYear W28997651592019 @default.
• W2899765159 countsByYear W28997651592020 @default.
• W2899765159 countsByYear W28997651592021 @default.
• W2899765159 countsByYear W28997651592022 @default.
• W2899765159 countsByYear W28997651592023 @default.
• W2899765159 crossrefType "journal-article" @default.
• W2899765159 hasAuthorship W2899765159A5022233224 @default.
• W2899765159 hasAuthorship W2899765159A5025445136 @default.
• W2899765159 hasAuthorship W2899765159A5027651871 @default.
• W2899765159 hasAuthorship W2899765159A5028600581 @default.
• W2899765159 hasAuthorship W2899765159A5039420443 @default.
• W2899765159 hasAuthorship W2899765159A5064342139 @default.
• W2899765159 hasAuthorship W2899765159A5065320081 @default.
• W2899765159 hasBestOaLocation W28997651591 @default.
• W2899765159 hasConcept C126322002 @default.
• W2899765159 hasConcept C141071460 @default.
• W2899765159 hasConcept C142724271 @default.
• W2899765159 hasConcept C197934379 @default.
• W2899765159 hasConcept C204787440 @default.
• W2899765159 hasConcept C27081682 @default.
• W2899765159 hasConcept C2778375690 @default.
• W2899765159 hasConcept C2778789114 @default.
• W2899765159 hasConcept C2778881276 @default.
• W2899765159 hasConcept C42219234 @default.
• W2899765159 hasConcept C71924100 @default.
• W2899765159 hasConceptScore W2899765159C126322002 @default.
• W2899765159 hasConceptScore W2899765159C141071460 @default.
• W2899765159 hasConceptScore W2899765159C142724271 @default.
• W2899765159 hasConceptScore W2899765159C197934379 @default.

• next